Cochlear | COH - Zinsaufwendungen Für Schuld

Aktienkurs
163.99
Täglich Wechseln
2.61 1.62%
Monatlich
-17.46%
Jährlich
-39.02%
Q1 Prognose
161.08




Zinsaufwendungen Für Schuld Veränderung Datum
Ansell USD 20.6M 300K 2025-12
Avita Medical AUD 1.25M 100K 2025-06
Cochlear AUD 6.3M 3.65M 2025-12
CSL USD 215M 111M 2025-12
Fisher Paykel Healthcare NZD 5.5M 700K 2025-12
Healius AUD 32.8M 15.4M 2024-12
Integral Diagnostics AUD 5.34M 6.08M 2024-06
Mayne Pharma AUD 1.2M 50K 2024-06
Mesoblast USD 10.83M 368K 2024-12
Monash IVF AUD 3.84M 2.43M 2025-06
Nanosonics AUD 779K 94K 2025-06
Polynovo AUD 506K 130K 2025-06
Ramsay Health Care AUD 300.6M 15.5M 2025-12
Regis Healthcare AUD 150K 30.92M 2025-12
ResMed USD 775K 886K 2024-12
Sigma Healthcare AUD 7.97M 365K 2024-01
Somnomed AUD 2.12M 1.62M 2023-06
Sonic Healthcare AUD 86.91M 43.94M 2024-12
Telix Pharmaceuticals AUD 7.62M 11.22M 2025-12